Biogen (BIIB) P/B (1999 - 2026)
Biogen (BIIB) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Biogen (BIIB) P/B is 1.58. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Biogen (BIIB)
| Year | P/B | Change |
|---|---|---|
| 2026 | 1.58 | +11.66% |
| 2025 | 1.41 | +6.02% |
| 2024 | 1.33 | -48.48% |
| 2023 | 2.59 | -17.35% |
| 2022 | 3.13 | -3.95% |
| 2021 | 3.26 | -9.24% |
| 2020 | 3.59 | -15.16% |
| 2019 | 4.23 | -11.24% |
| 2018 | 4.77 | -9.64% |
| 2017 | 5.28 | +2.95% |
| 2016 | 5.13 | -33.03% |
| 2015 | 7.65 | +2.98% |
| 2014 | 7.43 | -3.34% |
| 2013 | 7.69 | +54.64% |
| 2012 | 4.97 | +15.87% |
| 2011 | 4.29 | +43.98% |
| 2010 | 2.98 | +19.96% |
| 2009 | 2.48 | +106.73% |
| 2008 | 1.20 | +167.53% |
| 2007 | 0.45 | +15.71% |
| 2006 | 0.39 | +8.64% |
| 2005 | 0.36 | -32.02% |
| 2004 | 0.53 | +81.50% |
| 2003 | 0.29 | +10.64% |
| 2002 | 0.26 | -51.88% |
| 2001 | 0.54 | +9.09% |
| 2000 | 0.50 | +92.94% |
| 1999 | 0.26 | N/A |
Comparison Biogen (BIIB) P/B with competitors
Biogen (BIIB) P/B is 1.58.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -56.65% |
| GRFS | Grifols SA | 0.79 | -49.94% |
| SNY | Sanofi | 1.27 | -19.52% |
| PFE | Pfizer Inc | 1.55 | -1.90% |
| OGN | Organon & Company | 3.93 | +148.79% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | +159.25% |
| GSK | GSK Plc | 4.37 | +177.06% |
| BMY | Bristol-Myers Squibb Company | 6.04 | +282.76% |
| AZN | Astrazeneca plc | 6.20 | +292.90% |
| MRK | Merck & Co Inc | 6.68 | +323.32% |
| GILD | Gilead Sciences Inc | 6.94 | +339.79% |
| NVO | Novo Nordisk | 7.07 | +348.03% |
| NVS | Novartis AG | 7.60 | +381.62% |
| JNJ | Johnson & Johnson | 7.64 | +384.15% |
| NSRX | Nasus Pharma Ltd | 12.90 | +717.48% |
| MDCX | MDCorp | 15.34 | +872.11% |
| AMGN | AMGEN Inc | 21.17 | +1241.56% |
| SCLX | Scilex Holding Company | 28.85 | +1728.25% |
| LLY | Lilly(Eli) & Company | 32.94 | +1987.43% |
| ABBV | Abbvie Inc | 50.46 | +3097.69% |